Pharmaceutical

Will WHO’s new guidance spur hepatitis B immunisation?

Based on the updated guidelines, over 50% of individuals with chronic hepatitis B infections may require treatment.

Jun 22, 2024 - 04:00
Will WHO’s new guidance spur hepatitis B immunisation?
Based on the updated guidelines, over 50% of individuals with chronic hepatitis B infections may require treatment.
Read the original article

Tags:

Previous Article

AstraZeneca’s Truqap and Faslodex combo receives approval in EU

Next Article

Health-Tech Startup Evidation Opens Up Its Symptom-Logging App To Track Migraine...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FibroGen axes 75% of staff after lead cancer therapy fails in Phase III trials

FibroGen axes 75% of staff after lead cancer therapy fa...

Aug 1, 2024

Listen: 2023 in review, CEO report cards, and a look at the year ahead

Listen: 2023 in review, CEO report cards, and a look at...

Dec 21, 2023

Aseptic lyophilisation: Opportunities to improve quality and process monitoring with mass spectrometry

Aseptic lyophilisation: Opportunities to improve qualit...

Mar 23, 2023